Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.27273286 |
2 | modulation by symbiont of host defense response (GO:0052031) | 5.27273286 |
3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.27273286 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.27273286 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.27273286 |
6 | modulation by symbiont of host immune response (GO:0052553) | 5.27273286 |
7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.37167541 |
8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.37167541 |
9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.20429423 |
10 | low-density lipoprotein particle clearance (GO:0034383) | 3.87315076 |
11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.83696468 |
12 | response to peptidoglycan (GO:0032494) | 3.81483253 |
13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.71088614 |
14 | response to muramyl dipeptide (GO:0032495) | 3.63815917 |
15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.53549832 |
16 | macrophage activation involved in immune response (GO:0002281) | 3.49799870 |
17 | positive regulation of interferon-alpha production (GO:0032727) | 3.42622982 |
18 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.41973604 |
19 | regulation of interferon-alpha production (GO:0032647) | 3.33703110 |
20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33026144 |
21 | response to host immune response (GO:0052572) | 3.33026144 |
22 | negative regulation of interleukin-12 production (GO:0032695) | 3.29400694 |
23 | response to host (GO:0075136) | 3.24839116 |
24 | response to host defenses (GO:0052200) | 3.24839116 |
25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.24839116 |
26 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.24732136 |
27 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.20957247 |
28 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19539841 |
29 | regulation of cholesterol storage (GO:0010885) | 3.18858950 |
30 | mannose metabolic process (GO:0006013) | 3.12395180 |
31 | positive regulation of lipid storage (GO:0010884) | 3.08933279 |
32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01892027 |
33 | detection of other organism (GO:0098543) | 2.99792549 |
34 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.97563197 |
35 | positive regulation of p38MAPK cascade (GO:1900745) | 2.94483469 |
36 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94439054 |
37 | sarcomere organization (GO:0045214) | 2.90172129 |
38 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.89863994 |
39 | neutrophil activation involved in immune response (GO:0002283) | 2.89759958 |
40 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89574788 |
41 | detection of bacterium (GO:0016045) | 2.87073881 |
42 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.85443937 |
43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.83804641 |
44 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.82985815 |
45 | NIK/NF-kappaB signaling (GO:0038061) | 2.81614132 |
46 | positive regulation of histone deacetylation (GO:0031065) | 2.81179561 |
47 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79146843 |
48 | stress fiber assembly (GO:0043149) | 2.78968115 |
49 | cell adhesion mediated by integrin (GO:0033627) | 2.78576526 |
50 | pentose-phosphate shunt (GO:0006098) | 2.77856169 |
51 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.77567043 |
52 | immunoglobulin mediated immune response (GO:0016064) | 2.77509804 |
53 | regulation of necroptotic process (GO:0060544) | 2.73317345 |
54 | apoptotic cell clearance (GO:0043277) | 2.71568008 |
55 | respiratory burst (GO:0045730) | 2.71264778 |
56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68649910 |
57 | regulation of vitamin metabolic process (GO:0030656) | 2.67624344 |
58 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.65580165 |
59 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.64299685 |
60 | regulation of early endosome to late endosome transport (GO:2000641) | 2.60948537 |
61 | activation of MAPKKK activity (GO:0000185) | 2.58292752 |
62 | leukocyte aggregation (GO:0070486) | 2.58153370 |
63 | detection of external biotic stimulus (GO:0098581) | 2.57674841 |
64 | positive regulation of heat generation (GO:0031652) | 2.57588102 |
65 | cellular extravasation (GO:0045123) | 2.57480357 |
66 | barbed-end actin filament capping (GO:0051016) | 2.57236463 |
67 | positive regulation of B cell differentiation (GO:0045579) | 2.56768247 |
68 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.55353222 |
69 | regulation of podosome assembly (GO:0071801) | 2.54877293 |
70 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.52515092 |
71 | cellular response to zinc ion (GO:0071294) | 2.50476792 |
72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.50218150 |
73 | growth hormone receptor signaling pathway (GO:0060396) | 2.49650512 |
74 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.49593502 |
75 | regulation of p38MAPK cascade (GO:1900744) | 2.49163380 |
76 | plasma membrane repair (GO:0001778) | 2.49069990 |
77 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.48479014 |
78 | I-kappaB phosphorylation (GO:0007252) | 2.48137292 |
79 | defense response to protozoan (GO:0042832) | 2.47404371 |
80 | T cell apoptotic process (GO:0070231) | 2.47129260 |
81 | positive regulation of interferon-beta production (GO:0032728) | 2.47035090 |
82 | tolerance induction (GO:0002507) | 2.46597913 |
83 | response to protozoan (GO:0001562) | 2.46418142 |
84 | actin-myosin filament sliding (GO:0033275) | 2.44913398 |
85 | muscle filament sliding (GO:0030049) | 2.44913398 |
86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44908910 |
87 | regulation of integrin activation (GO:0033623) | 2.44799765 |
88 | cardiac myofibril assembly (GO:0055003) | 2.44412757 |
89 | regulation of necrotic cell death (GO:0010939) | 2.44278385 |
90 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.43909346 |
91 | regulation of leukocyte degranulation (GO:0043300) | 2.43847368 |
92 | NADPH regeneration (GO:0006740) | 2.42694796 |
93 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.42594629 |
94 | response to type I interferon (GO:0034340) | 2.42160099 |
95 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.41247232 |
96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.39396505 |
97 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.39297776 |
98 | myofibril assembly (GO:0030239) | 2.38669630 |
99 | cellular response to type I interferon (GO:0071357) | 2.38556603 |
100 | type I interferon signaling pathway (GO:0060337) | 2.38556603 |
101 | T-helper 1 type immune response (GO:0042088) | 2.38307804 |
102 | negative regulation of growth of symbiont in host (GO:0044130) | 2.36843679 |
103 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.36843679 |
104 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.36843679 |
105 | regulation of growth of symbiont in host (GO:0044126) | 2.36843679 |
106 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.36438503 |
107 | negative regulation of lipid storage (GO:0010888) | 2.36244528 |
108 | response to fungus (GO:0009620) | 2.35119500 |
109 | negative regulation of necroptotic process (GO:0060546) | 2.34899475 |
110 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.34341635 |
111 | myeloid dendritic cell activation (GO:0001773) | 2.34027678 |
112 | adhesion of symbiont to host cell (GO:0044650) | 2.33787157 |
113 | virion attachment to host cell (GO:0019062) | 2.33787157 |
114 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.33444633 |
115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.32967328 |
116 | neutrophil mediated immunity (GO:0002446) | 2.32738954 |
117 | response to laminar fluid shear stress (GO:0034616) | 2.32371061 |
118 | germinal center formation (GO:0002467) | 2.32154536 |
119 | glycosphingolipid catabolic process (GO:0046479) | 2.31906058 |
120 | detection of molecule of bacterial origin (GO:0032490) | 2.31534819 |
121 | leukocyte cell-cell adhesion (GO:0007159) | 2.31279681 |
122 | detection of biotic stimulus (GO:0009595) | 2.29619038 |
123 | positive regulation of antigen processing and presentation (GO:0002579) | 2.29415187 |
124 | protein localization to endosome (GO:0036010) | 2.29176320 |
125 | regulation of type 2 immune response (GO:0002828) | 2.29144436 |
126 | regulation of mast cell degranulation (GO:0043304) | 2.28492682 |
127 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.28342151 |
128 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.27856647 |
129 | positive regulation of type 2 immune response (GO:0002830) | 2.27356540 |
130 | myeloid dendritic cell differentiation (GO:0043011) | 2.27180872 |
131 | negative regulation of cell killing (GO:0031342) | 2.26795841 |
132 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.26795841 |
133 | apoptotic process involved in morphogenesis (GO:0060561) | 2.26740499 |
134 | positive thymic T cell selection (GO:0045059) | 2.26243273 |
135 | regulation of lipid storage (GO:0010883) | 2.26017573 |
136 | regulation of chemokine biosynthetic process (GO:0045073) | 2.25881821 |
137 | modulation by symbiont of host cellular process (GO:0044068) | 2.25549830 |
138 | hepatocyte apoptotic process (GO:0097284) | 2.25255959 |
139 | embryonic process involved in female pregnancy (GO:0060136) | 2.24806363 |
140 | cellular response to virus (GO:0098586) | 2.24511296 |
141 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.22095052 |
142 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.21966929 |
143 | granulocyte activation (GO:0036230) | 2.20559659 |
144 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.20323031 |
145 | negative regulation of granulocyte differentiation (GO:0030853) | 2.19556124 |
146 | negative regulation of type 2 immune response (GO:0002829) | 2.17203793 |
147 | adhesion of symbiont to host (GO:0044406) | 2.15797438 |
148 | mature B cell differentiation involved in immune response (GO:0002313) | 2.15566669 |
149 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.15200524 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.82540879 |
2 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.68568482 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.56030735 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.17002776 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.01513028 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.94939962 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72778176 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66816637 |
9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.64748192 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63598360 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.61544966 |
12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.43721761 |
13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.39641127 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.37655701 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37340973 |
16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.37292717 |
17 | MYC_22102868_ChIP-Seq_BL_Human | 2.30950773 |
18 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.25041104 |
19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.23988619 |
20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19301131 |
21 | MAF_26560356_Chip-Seq_TH1_Human | 2.00318951 |
22 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.99731894 |
23 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94849041 |
24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.94002728 |
25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.92900581 |
26 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.90689262 |
27 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.90591296 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85763269 |
29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.85244723 |
30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83282495 |
31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.82715138 |
32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.81542087 |
33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80404278 |
34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.77595840 |
35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75901579 |
36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71141641 |
37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69649589 |
38 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69287602 |
39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68325021 |
40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67085929 |
41 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64184632 |
42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64135439 |
43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63225932 |
44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60777551 |
45 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58987705 |
46 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58789049 |
47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58000318 |
48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57798603 |
49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56742908 |
50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56213774 |
51 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55153200 |
52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54662751 |
53 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.54548537 |
54 | MYB_26560356_Chip-Seq_TH2_Human | 1.53995267 |
55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49646116 |
56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46833794 |
57 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.44241750 |
58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42443934 |
59 | MYB_26560356_Chip-Seq_TH1_Human | 1.41997137 |
60 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41578490 |
61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41032025 |
62 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40080175 |
63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39129224 |
64 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38150586 |
65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.34413559 |
66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31672609 |
67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30909697 |
68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.29289859 |
69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28669491 |
70 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28157578 |
71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26611823 |
72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25596919 |
73 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24520515 |
74 | * MAF_26560356_Chip-Seq_TH2_Human | 1.24019781 |
75 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.23591786 |
76 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17866913 |
77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17432500 |
78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17100395 |
79 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16729145 |
80 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16729145 |
81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16542883 |
82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14297712 |
83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14195136 |
84 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13368588 |
85 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.13241672 |
86 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12385031 |
87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11821440 |
88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11643747 |
89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09161202 |
90 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08514230 |
91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08259348 |
92 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07750208 |
93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07301675 |
94 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07136817 |
95 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05460065 |
96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04949781 |
97 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04275573 |
98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03655359 |
99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02653412 |
100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01858213 |
101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01633528 |
102 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01324581 |
103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00918955 |
104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00424076 |
105 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00204016 |
106 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00150463 |
107 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99745939 |
108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99587893 |
109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98621246 |
110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96591699 |
111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96092090 |
112 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95641344 |
113 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95534646 |
114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95452611 |
115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94617717 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94488890 |
117 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92717456 |
118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90687335 |
119 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.90663081 |
120 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90302594 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 3.46445236 |
2 | MP0005451_abnormal_body_composition | 3.19171102 |
3 | MP0003300_gastrointestinal_ulcer | 2.90399214 |
4 | MP0004510_myositis | 2.59225093 |
5 | MP0003436_decreased_susceptibility_to | 2.56793772 |
6 | MP0003705_abnormal_hypodermis_morpholog | 2.41625156 |
7 | MP0009278_abnormal_bone_marrow | 2.15987522 |
8 | MP0001835_abnormal_antigen_presentation | 2.14605600 |
9 | MP0003646_muscle_fatigue | 2.01770092 |
10 | MP0004084_abnormal_cardiac_muscle | 1.98902774 |
11 | MP0000685_abnormal_immune_system | 1.97646265 |
12 | * MP0009785_altered_susceptibility_to | 1.97583762 |
13 | MP0005058_abnormal_lysosome_morphology | 1.94729867 |
14 | MP0003566_abnormal_cell_adhesion | 1.90109019 |
15 | * MP0002419_abnormal_innate_immunity | 1.86950071 |
16 | MP0001790_abnormal_immune_system | 1.78881925 |
17 | MP0005387_immune_system_phenotype | 1.78881925 |
18 | MP0004947_skin_inflammation | 1.76083093 |
19 | * MP0005025_abnormal_response_to | 1.73478901 |
20 | MP0005000_abnormal_immune_tolerance | 1.71818543 |
21 | MP0010352_gastrointestinal_tract_polyps | 1.68195454 |
22 | MP0005076_abnormal_cell_differentiation | 1.66409142 |
23 | MP0002877_abnormal_melanocyte_morpholog | 1.64527819 |
24 | MP0002837_dystrophic_cardiac_calcinosis | 1.62821736 |
25 | * MP0000343_altered_response_to | 1.62123326 |
26 | MP0001800_abnormal_humoral_immune | 1.59338413 |
27 | * MP0002452_abnormal_antigen_presenting | 1.58154389 |
28 | MP0008438_abnormal_cutaneous_collagen | 1.56730756 |
29 | MP0006082_CNS_inflammation | 1.55350321 |
30 | MP0001533_abnormal_skeleton_physiology | 1.54654595 |
31 | MP0003724_increased_susceptibility_to | 1.54596149 |
32 | MP0003828_pulmonary_edema | 1.54299150 |
33 | MP0003191_abnormal_cellular_cholesterol | 1.53669563 |
34 | MP0000750_abnormal_muscle_regeneration | 1.52348366 |
35 | MP0005464_abnormal_platelet_physiology | 1.51990968 |
36 | MP0008260_abnormal_autophagy | 1.51634356 |
37 | MP0008004_abnormal_stomach_pH | 1.51188914 |
38 | MP0004130_abnormal_muscle_cell | 1.49813882 |
39 | MP0004087_abnormal_muscle_fiber | 1.45586924 |
40 | MP0000751_myopathy | 1.44520947 |
41 | MP0002148_abnormal_hypersensitivity_rea | 1.44258136 |
42 | MP0001853_heart_inflammation | 1.44074058 |
43 | * MP0002723_abnormal_immune_serum | 1.43735915 |
44 | MP0010630_abnormal_cardiac_muscle | 1.42997343 |
45 | MP0003448_altered_tumor_morphology | 1.39279528 |
46 | MP0002166_altered_tumor_susceptibility | 1.38448412 |
47 | MP0010307_abnormal_tumor_latency | 1.37597293 |
48 | MP0005330_cardiomyopathy | 1.33973177 |
49 | * MP0003221_abnormal_cardiomyocyte_apopto | 1.33482684 |
50 | MP0002405_respiratory_system_inflammati | 1.32127748 |
51 | MP0004808_abnormal_hematopoietic_stem | 1.31855705 |
52 | MP0004036_abnormal_muscle_relaxation | 1.31359459 |
53 | MP0002254_reproductive_system_inflammat | 1.31307591 |
54 | * MP0001819_abnormal_immune_cell | 1.30075967 |
55 | MP0003763_abnormal_thymus_physiology | 1.29949129 |
56 | * MP0002420_abnormal_adaptive_immunity | 1.29347329 |
57 | MP0001849_ear_inflammation | 1.26456373 |
58 | MP0002332_abnormal_exercise_endurance | 1.25918153 |
59 | MP0001545_abnormal_hematopoietic_system | 1.24605447 |
60 | MP0005397_hematopoietic_system_phenotyp | 1.24605447 |
61 | MP0005023_abnormal_wound_healing | 1.24155975 |
62 | * MP0001845_abnormal_inflammatory_respons | 1.24151583 |
63 | MP0000733_abnormal_muscle_development | 1.24095477 |
64 | MP0001958_emphysema | 1.22398532 |
65 | MP0004185_abnormal_adipocyte_glucose | 1.22386394 |
66 | * MP0010155_abnormal_intestine_physiology | 1.19293373 |
67 | * MP0008469_abnormal_protein_level | 1.17469605 |
68 | MP0003091_abnormal_cell_migration | 1.17261224 |
69 | MP0000749_muscle_degeneration | 1.16022929 |
70 | MP0003172_abnormal_lysosome_physiology | 1.15190398 |
71 | MP0009764_decreased_sensitivity_to | 1.13896321 |
72 | MP0005666_abnormal_adipose_tissue | 1.13184299 |
73 | MP0001544_abnormal_cardiovascular_syste | 1.12351354 |
74 | MP0005385_cardiovascular_system_phenoty | 1.12351354 |
75 | MP0004858_abnormal_nervous_system | 1.09115759 |
76 | MP0005166_decreased_susceptibility_to | 1.08909813 |
77 | MP0002106_abnormal_muscle_physiology | 1.08523344 |
78 | MP0000858_altered_metastatic_potential | 1.08017842 |
79 | MP0002398_abnormal_bone_marrow | 1.07988037 |
80 | * MP0009840_abnormal_foam_cell | 1.07892968 |
81 | MP0002972_abnormal_cardiac_muscle | 1.07125972 |
82 | MP0003279_aneurysm | 1.06144887 |
83 | MP0005671_abnormal_response_to | 1.05793209 |
84 | * MP0000716_abnormal_immune_system | 1.04605693 |
85 | MP0002006_tumorigenesis | 1.03968541 |
86 | MP0005375_adipose_tissue_phenotype | 1.02373979 |
87 | MP0000604_amyloidosis | 1.01540176 |
88 | MP0009333_abnormal_splenocyte_physiolog | 1.00499348 |
89 | MP0005083_abnormal_biliary_tract | 0.99678320 |
90 | MP0002998_abnormal_bone_remodeling | 0.98846121 |
91 | MP0008775_abnormal_heart_ventricle | 0.98362109 |
92 | MP0005390_skeleton_phenotype | 0.98346667 |
93 | MP0001873_stomach_inflammation | 0.97497028 |
94 | MP0003656_abnormal_erythrocyte_physiolo | 0.95747876 |
95 | MP0001851_eye_inflammation | 0.95696973 |
96 | * MP0000689_abnormal_spleen_morphology | 0.94965605 |
97 | MP0002933_joint_inflammation | 0.94813485 |
98 | MP0002138_abnormal_hepatobiliary_system | 0.94637738 |
99 | MP0000767_abnormal_smooth_muscle | 0.93845622 |
100 | MP0002396_abnormal_hematopoietic_system | 0.92522487 |
101 | MP0004233_abnormal_muscle_weight | 0.92386843 |
102 | * MP0002429_abnormal_blood_cell | 0.91969139 |
103 | MP0000609_abnormal_liver_physiology | 0.91499289 |
104 | MP0002722_abnormal_immune_system | 0.90483559 |
105 | MP0003075_altered_response_to | 0.89658014 |
106 | MP0003453_abnormal_keratinocyte_physiol | 0.88348654 |
107 | MP0009763_increased_sensitivity_to | 0.87755987 |
108 | MP0005164_abnormal_response_to | 0.87687875 |
109 | MP0010234_abnormal_vibrissa_follicle | 0.87386043 |
110 | MP0000249_abnormal_blood_vessel | 0.87025819 |
111 | MP0005257_abnormal_intraocular_pressure | 0.86235697 |
112 | MP0002796_impaired_skin_barrier | 0.85679313 |
113 | MP0005319_abnormal_enzyme/_coenzyme | 0.84936935 |
114 | MP0004215_abnormal_myocardial_fiber | 0.84906640 |
115 | MP0005310_abnormal_salivary_gland | 0.82354656 |
116 | MP0005409_darkened_coat_color | 0.82016945 |
117 | MP0005167_abnormal_blood-brain_barrier | 0.80985739 |
118 | MP0003795_abnormal_bone_structure | 0.79424906 |
119 | MP0000759_abnormal_skeletal_muscle | 0.79171701 |
120 | MP0000747_muscle_weakness | 0.78220240 |
121 | MP0001542_abnormal_bone_strength | 0.78201387 |
122 | MP0002269_muscular_atrophy | 0.78147105 |
123 | MP0005165_increased_susceptibility_to | 0.76631491 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.33733200 |
2 | Recurrent abscess formation (HP:0002722) | 3.79717064 |
3 | Recurrent bacterial skin infections (HP:0005406) | 3.52301762 |
4 | Exercise-induced muscle cramps (HP:0003710) | 3.44458977 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42541434 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42541434 |
7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42541434 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39600525 |
9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.24691110 |
10 | Asymmetric septal hypertrophy (HP:0001670) | 3.11242100 |
11 | Myositis (HP:0100614) | 2.97730396 |
12 | Ventricular tachycardia (HP:0004756) | 2.96403686 |
13 | Hematochezia (HP:0002573) | 2.95991235 |
14 | Interstitial pulmonary disease (HP:0006530) | 2.93507272 |
15 | Increased connective tissue (HP:0009025) | 2.93083326 |
16 | Distal lower limb muscle weakness (HP:0009053) | 2.87084225 |
17 | Abnormality of macrophages (HP:0004311) | 2.86559074 |
18 | Sudden death (HP:0001699) | 2.82053367 |
19 | Orchitis (HP:0100796) | 2.79081667 |
20 | Increased density of long bones (HP:0006392) | 2.76184460 |
21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.73678712 |
22 | Subaortic stenosis (HP:0001682) | 2.73678712 |
23 | Muscle fiber splitting (HP:0003555) | 2.66675886 |
24 | Mediastinal lymphadenopathy (HP:0100721) | 2.66081344 |
25 | Distal lower limb amyotrophy (HP:0008944) | 2.65106584 |
26 | Increased cerebral lipofuscin (HP:0011813) | 2.63222733 |
27 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.63114441 |
28 | Hyporeflexia of lower limbs (HP:0002600) | 2.62201605 |
29 | Myoglobinuria (HP:0002913) | 2.60720716 |
30 | Frequent falls (HP:0002359) | 2.54113956 |
31 | Increased variability in muscle fiber diameter (HP:0003557) | 2.52906693 |
32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.52459830 |
33 | Exercise-induced myalgia (HP:0003738) | 2.51801139 |
34 | Myocardial infarction (HP:0001658) | 2.50412078 |
35 | Loss of speech (HP:0002371) | 2.46998511 |
36 | Systemic lupus erythematosus (HP:0002725) | 2.46331122 |
37 | Peritonitis (HP:0002586) | 2.46263581 |
38 | Cellulitis (HP:0100658) | 2.45312927 |
39 | Stomatitis (HP:0010280) | 2.45170853 |
40 | Cerebral aneurysm (HP:0004944) | 2.44126416 |
41 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39508880 |
42 | Osteolytic defects of the hand bones (HP:0009699) | 2.39508880 |
43 | Increased IgE level (HP:0003212) | 2.38761842 |
44 | Lipoatrophy (HP:0100578) | 2.35883152 |
45 | Autoimmune thrombocytopenia (HP:0001973) | 2.35776137 |
46 | Recurrent fungal infections (HP:0002841) | 2.35357748 |
47 | Right ventricular cardiomyopathy (HP:0011663) | 2.32138474 |
48 | Esophageal neoplasm (HP:0100751) | 2.30625198 |
49 | Neoplasm of head and neck (HP:0012288) | 2.30625198 |
50 | Arterial thrombosis (HP:0004420) | 2.28884629 |
51 | Spontaneous hematomas (HP:0007420) | 2.26396636 |
52 | Rhabdomyolysis (HP:0003201) | 2.25085817 |
53 | Thin bony cortex (HP:0002753) | 2.24503574 |
54 | Gingivitis (HP:0000230) | 2.22239544 |
55 | Premature rupture of membranes (HP:0001788) | 2.20697202 |
56 | Abnormality of the nasal mucosa (HP:0000433) | 2.18178468 |
57 | Difficulty running (HP:0009046) | 2.16720322 |
58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15422953 |
59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15422953 |
60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15422953 |
61 | Recurrent skin infections (HP:0001581) | 2.14865564 |
62 | Urticaria (HP:0001025) | 2.14307035 |
63 | Tetraparesis (HP:0002273) | 2.13977101 |
64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13613124 |
65 | Mucopolysacchariduria (HP:0008155) | 2.13445964 |
66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13445964 |
67 | Retrobulbar optic neuritis (HP:0100654) | 2.12216549 |
68 | Optic neuritis (HP:0100653) | 2.12216549 |
69 | Calf muscle hypertrophy (HP:0008981) | 2.12040821 |
70 | EMG: myopathic abnormalities (HP:0003458) | 2.11914707 |
71 | Axonal loss (HP:0003447) | 2.10270072 |
72 | Chronic otitis media (HP:0000389) | 2.09921746 |
73 | Recurrent viral infections (HP:0004429) | 2.08105579 |
74 | Persistence of primary teeth (HP:0006335) | 2.06852146 |
75 | Spondylolisthesis (HP:0003302) | 2.05242576 |
76 | Difficulty climbing stairs (HP:0003551) | 2.03517232 |
77 | Type 1 muscle fiber predominance (HP:0003803) | 2.02119363 |
78 | Achilles tendon contracture (HP:0001771) | 2.01709629 |
79 | Nausea (HP:0002018) | 2.01607027 |
80 | Gastrointestinal stroma tumor (HP:0100723) | 1.99405035 |
81 | Vasculitis (HP:0002633) | 1.98805107 |
82 | Malnutrition (HP:0004395) | 1.98286657 |
83 | Nasal polyposis (HP:0100582) | 1.97193472 |
84 | Nuclear cataract (HP:0100018) | 1.94976869 |
85 | Chest pain (HP:0100749) | 1.94209617 |
86 | Esophageal varix (HP:0002040) | 1.92988388 |
87 | Colitis (HP:0002583) | 1.92867560 |
88 | Mucosal telangiectasiae (HP:0100579) | 1.90846182 |
89 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89554666 |
90 | Periodontitis (HP:0000704) | 1.88847949 |
91 | Long toe (HP:0010511) | 1.88812157 |
92 | Emphysema (HP:0002097) | 1.88611926 |
93 | Porencephaly (HP:0002132) | 1.88589452 |
94 | Limb-girdle muscle atrophy (HP:0003797) | 1.88391254 |
95 | Obstructive lung disease (HP:0006536) | 1.87568015 |
96 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87568015 |
97 | Ulnar deviation of the wrist (HP:0003049) | 1.87405300 |
98 | Cervical subluxation (HP:0003308) | 1.87123201 |
99 | Osteomyelitis (HP:0002754) | 1.87061224 |
100 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.86879422 |
101 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85993970 |
102 | Conjunctival hamartoma (HP:0100780) | 1.84607747 |
103 | Abnormality of the calf musculature (HP:0001430) | 1.84414522 |
104 | Vacuolated lymphocytes (HP:0001922) | 1.84329264 |
105 | Gastrointestinal infarctions (HP:0005244) | 1.83986466 |
106 | Polycythemia (HP:0001901) | 1.83826587 |
107 | Purpura (HP:0000979) | 1.83581707 |
108 | Increased serum ferritin (HP:0003281) | 1.83315070 |
109 | Bulbar palsy (HP:0001283) | 1.83056681 |
110 | Vertebral compression fractures (HP:0002953) | 1.83047939 |
111 | Aneurysm (HP:0002617) | 1.82969615 |
112 | Dilatation of the ascending aorta (HP:0005111) | 1.82750032 |
113 | Neurofibrillary tangles (HP:0002185) | 1.81737008 |
114 | Muscle fiber inclusion bodies (HP:0100299) | 1.80607339 |
115 | Pulmonary infiltrates (HP:0002113) | 1.80283671 |
116 | Abnormality of the Achilles tendon (HP:0005109) | 1.79699437 |
117 | Dilated cardiomyopathy (HP:0001644) | 1.79218366 |
118 | Protrusio acetabuli (HP:0003179) | 1.78995866 |
119 | Inflammation of the large intestine (HP:0002037) | 1.78937527 |
120 | Abnormality of complement system (HP:0005339) | 1.77930100 |
121 | Gastrointestinal inflammation (HP:0004386) | 1.77861543 |
122 | Bone pain (HP:0002653) | 1.77225306 |
123 | Impaired platelet aggregation (HP:0003540) | 1.77067899 |
124 | Abnormal platelet function (HP:0011869) | 1.77067899 |
125 | Dysostosis multiplex (HP:0000943) | 1.76967736 |
126 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.76689539 |
127 | Hemorrhage of the eye (HP:0011885) | 1.76320612 |
128 | Spinal rigidity (HP:0003306) | 1.75802048 |
129 | Broad face (HP:0000283) | 1.75541616 |
130 | Hepatosplenomegaly (HP:0001433) | 1.73868906 |
131 | Pustule (HP:0200039) | 1.73779991 |
132 | Polygenic inheritance (HP:0010982) | 1.73677538 |
133 | Ulnar bowing (HP:0003031) | 1.73578483 |
134 | Aortic aneurysm (HP:0004942) | 1.73431934 |
135 | Facial diplegia (HP:0001349) | 1.72454102 |
136 | Meningitis (HP:0001287) | 1.71635150 |
137 | Obstructive sleep apnea (HP:0002870) | 1.71490478 |
138 | Flat acetabular roof (HP:0003180) | 1.70920903 |
139 | Thrombocytosis (HP:0001894) | 1.70839174 |
140 | Amyloidosis (HP:0011034) | 1.70607112 |
141 | Cerebral inclusion bodies (HP:0100314) | 1.69914069 |
142 | Abnormality of the thoracic spine (HP:0100711) | 1.69813410 |
143 | Hyperparathyroidism (HP:0000843) | 1.69772854 |
144 | Myopathic facies (HP:0002058) | 1.69127649 |
145 | Thoracic kyphosis (HP:0002942) | 1.68446751 |
146 | Restrictive lung disease (HP:0002091) | 1.66781376 |
147 | Glomerulonephritis (HP:0000099) | 1.65648961 |
148 | Keratoconjunctivitis sicca (HP:0001097) | 1.64476108 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.43524130 |
2 | TTN | 3.97498172 |
3 | PKN2 | 3.72797652 |
4 | PRPF4B | 3.58629083 |
5 | ERN1 | 3.00711064 |
6 | TBK1 | 2.76503858 |
7 | MAP4K1 | 2.40153772 |
8 | MAP3K10 | 2.39577541 |
9 | TYK2 | 2.25202954 |
10 | EPHB1 | 2.10502115 |
11 | PTK6 | 1.98969482 |
12 | EEF2K | 1.97996243 |
13 | TAOK2 | 1.97479929 |
14 | MAP3K14 | 1.81032673 |
15 | IRAK3 | 1.80410745 |
16 | LRRK2 | 1.79357790 |
17 | MAP2K3 | 1.76355229 |
18 | SMG1 | 1.74912928 |
19 | ICK | 1.73772830 |
20 | CDC42BPA | 1.69834619 |
21 | STK10 | 1.64239209 |
22 | JAK3 | 1.57290433 |
23 | RIPK1 | 1.56493800 |
24 | MAP3K13 | 1.53623787 |
25 | KIT | 1.43873903 |
26 | JAK1 | 1.42494353 |
27 | IKBKE | 1.40512688 |
28 | IRAK4 | 1.39270474 |
29 | BLK | 1.39200410 |
30 | DMPK | 1.35818921 |
31 | FGFR4 | 1.35674010 |
32 | ZAP70 | 1.34398336 |
33 | DDR2 | 1.33748759 |
34 | TGFBR2 | 1.32128945 |
35 | CDK6 | 1.29717804 |
36 | NEK9 | 1.24143407 |
37 | RPS6KA4 | 1.21505457 |
38 | SIK1 | 1.21030737 |
39 | CDK4 | 1.15154308 |
40 | TAOK3 | 1.13989928 |
41 | CSK | 1.13849771 |
42 | MAP3K5 | 1.13130250 |
43 | IKBKB | 1.12788351 |
44 | FLT3 | 1.11948137 |
45 | MOS | 1.11690952 |
46 | BMX | 1.10534432 |
47 | PAK4 | 1.07748086 |
48 | BTK | 1.06481504 |
49 | SIK3 | 1.06306813 |
50 | MAP3K6 | 1.05792310 |
51 | KSR2 | 1.05465093 |
52 | STK24 | 1.00695876 |
53 | STK3 | 1.00158259 |
54 | MAP3K3 | 1.00073145 |
55 | CAMK1D | 0.99774893 |
56 | HCK | 0.99727315 |
57 | OBSCN | 0.96797056 |
58 | IRAK2 | 0.95055369 |
59 | PRKD2 | 0.92817606 |
60 | STK4 | 0.92752793 |
61 | MARK2 | 0.92695436 |
62 | MAP3K11 | 0.90410016 |
63 | JAK2 | 0.90073869 |
64 | CHUK | 0.89070565 |
65 | CSF1R | 0.88384543 |
66 | CDK12 | 0.86584594 |
67 | GRK7 | 0.84236636 |
68 | PDGFRA | 0.83937837 |
69 | TESK1 | 0.83337406 |
70 | EPHA3 | 0.82949370 |
71 | ALK | 0.81743712 |
72 | FGFR3 | 0.81136524 |
73 | PDPK1 | 0.80579920 |
74 | RIPK4 | 0.80054809 |
75 | HIPK2 | 0.76707588 |
76 | IRAK1 | 0.76004323 |
77 | MAPK12 | 0.75657671 |
78 | LATS2 | 0.73871791 |
79 | NME2 | 0.72592416 |
80 | RPS6KC1 | 0.72374151 |
81 | RPS6KL1 | 0.72374151 |
82 | ARAF | 0.72358301 |
83 | PIM1 | 0.70972366 |
84 | BCKDK | 0.68997710 |
85 | RPS6KA2 | 0.68573154 |
86 | ILK | 0.67906663 |
87 | TRPM7 | 0.65589983 |
88 | ITK | 0.64793576 |
89 | MAPK7 | 0.64151960 |
90 | MAP3K8 | 0.63625676 |
91 | SCYL2 | 0.63406446 |
92 | KDR | 0.61403942 |
93 | TXK | 0.60913404 |
94 | LCK | 0.60405091 |
95 | SYK | 0.60343291 |
96 | LMTK2 | 0.60210079 |
97 | MAP3K7 | 0.59340583 |
98 | GRK6 | 0.58819995 |
99 | TESK2 | 0.57245973 |
100 | TAOK1 | 0.56361384 |
101 | MTOR | 0.56314318 |
102 | PDK1 | 0.56040940 |
103 | EGFR | 0.55708281 |
104 | RET | 0.55589504 |
105 | EPHA2 | 0.55138158 |
106 | MARK3 | 0.54337451 |
107 | PIM2 | 0.53962378 |
108 | CAMK1G | 0.52664503 |
109 | LATS1 | 0.50053562 |
110 | PDGFRB | 0.48762179 |
111 | PTK2 | 0.48206304 |
112 | DYRK1B | 0.47982003 |
113 | PRKG2 | 0.47481027 |
114 | MATK | 0.47176324 |
115 | BMPR2 | 0.46353959 |
116 | MAPK11 | 0.46029797 |
117 | FES | 0.44760943 |
118 | RPS6KA6 | 0.44597897 |
119 | CDK9 | 0.44112115 |
120 | MYLK | 0.43825697 |
121 | MAP3K1 | 0.43772884 |
122 | TGFBR1 | 0.43090123 |
123 | FGR | 0.43025017 |
124 | LYN | 0.42448806 |
125 | PRKD1 | 0.42270382 |
126 | TIE1 | 0.42154217 |
127 | TEC | 0.41849748 |
128 | PRKAA2 | 0.41840347 |
129 | MST1R | 0.40326124 |
130 | NEK2 | 0.40228693 |
131 | PAK2 | 0.39142673 |
132 | ABL1 | 0.38168320 |
133 | PIK3CG | 0.37805564 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92439327 |
2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32367366 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26057609 |
4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.06303838 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.01280715 |
6 | Legionellosis_Homo sapiens_hsa05134 | 1.98925865 |
7 | Malaria_Homo sapiens_hsa05144 | 1.88655343 |
8 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.81478819 |
9 | Pertussis_Homo sapiens_hsa05133 | 1.78893782 |
10 | Viral myocarditis_Homo sapiens_hsa05416 | 1.77352725 |
11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74411315 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74255102 |
13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.69722615 |
14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69350432 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66075325 |
16 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.60905039 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 1.59274755 |
18 | Measles_Homo sapiens_hsa05162 | 1.53188960 |
19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.50801231 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48635016 |
21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47862706 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43239839 |
23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42033133 |
24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41949048 |
25 | Bladder cancer_Homo sapiens_hsa05219 | 1.39049665 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.38101324 |
27 | Insulin resistance_Homo sapiens_hsa04931 | 1.36277336 |
28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.36239103 |
29 | Apoptosis_Homo sapiens_hsa04210 | 1.34938813 |
30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.32339112 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31644930 |
32 | Shigellosis_Homo sapiens_hsa05131 | 1.30572123 |
33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29467907 |
34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.27844710 |
35 | Amoebiasis_Homo sapiens_hsa05146 | 1.27647576 |
36 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.24619833 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21000796 |
38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20940692 |
39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20343864 |
40 | Prion diseases_Homo sapiens_hsa05020 | 1.20326698 |
41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19689396 |
42 | Salmonella infection_Homo sapiens_hsa05132 | 1.17563349 |
43 | Asthma_Homo sapiens_hsa05310 | 1.17235145 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.15800998 |
45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15474884 |
46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.12411282 |
47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11648489 |
48 | Lysosome_Homo sapiens_hsa04142 | 1.10019956 |
49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09141413 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06757237 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05339553 |
52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02007444 |
53 | Focal adhesion_Homo sapiens_hsa04510 | 0.99213689 |
54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99026060 |
55 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.95679862 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.92437896 |
57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92390131 |
58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91729183 |
59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88677529 |
60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88668535 |
61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.86755131 |
62 | Allograft rejection_Homo sapiens_hsa05330 | 0.86549414 |
63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82505104 |
64 | Platelet activation_Homo sapiens_hsa04611 | 0.81508692 |
65 | Lysine degradation_Homo sapiens_hsa00310 | 0.80912012 |
66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80738600 |
67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80608797 |
68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80054531 |
69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79461719 |
70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78952989 |
71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78914226 |
72 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78465763 |
73 | Phagosome_Homo sapiens_hsa04145 | 0.76801051 |
74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75691317 |
75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75563014 |
76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74486625 |
77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74290357 |
78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74116402 |
79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72621719 |
80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71255471 |
81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70404480 |
82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70309668 |
83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69609536 |
84 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68859089 |
85 | Prostate cancer_Homo sapiens_hsa05215 | 0.67813134 |
86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67741622 |
87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67268980 |
88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66816295 |
89 | Glioma_Homo sapiens_hsa05214 | 0.66498816 |
90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66483592 |
91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66427942 |
92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66396771 |
93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66121413 |
94 | Endocytosis_Homo sapiens_hsa04144 | 0.65342203 |
95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65079549 |
96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64791469 |
97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64767330 |
98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64739248 |
99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63631981 |
100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63546585 |
101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61529086 |
102 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61479218 |
103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61189027 |
104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60333094 |
105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60145370 |
106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56654816 |
107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56506251 |
108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55966965 |
109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55236510 |
110 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55171933 |
111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54889594 |
112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54421786 |
113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53250257 |
114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53043964 |
115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51473252 |
116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50654102 |
117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49479441 |
118 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48013974 |
119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47563254 |
120 | Adherens junction_Homo sapiens_hsa04520 | 0.46511780 |
121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46251950 |
122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46023166 |
123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45747720 |